264 related articles for article (PubMed ID: 30830361)
21. Metabolomics in endometrial cancer diagnosis: A systematic review.
Raffone A; Troisi J; Boccia D; Travaglino A; Capuano G; Insabato L; Mollo A; Guida M; Zullo F
Acta Obstet Gynecol Scand; 2020 Sep; 99(9):1135-1146. PubMed ID: 32180221
[TBL] [Abstract][Full Text] [Related]
22. Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis.
Mayerle J; Kalthoff H; Reszka R; Kamlage B; Peter E; Schniewind B; González Maldonado S; Pilarsky C; Heidecke CD; Schatz P; Distler M; Scheiber JA; Mahajan UM; Weiss FU; Grützmann R; Lerch MM
Gut; 2018 Jan; 67(1):128-137. PubMed ID: 28108468
[TBL] [Abstract][Full Text] [Related]
23. Serum metabolomics differentiating pancreatic cancer from new-onset diabetes.
He X; Zhong J; Wang S; Zhou Y; Wang L; Zhang Y; Yuan Y
Oncotarget; 2017 Apr; 8(17):29116-29124. PubMed ID: 28418859
[TBL] [Abstract][Full Text] [Related]
24. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
[TBL] [Abstract][Full Text] [Related]
25. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
27. Salivary metabolomic biomarkers for non-invasive lung cancer detection.
Kajiwara N; Kakihana M; Maeda J; Kaneko M; Ota S; Enomoto A; Ikeda N; Sugimoto M
Cancer Sci; 2024 May; 115(5):1695-1705. PubMed ID: 38417449
[TBL] [Abstract][Full Text] [Related]
28. Metabolomic identification of diagnostic serum-based biomarkers for advanced stage melanoma.
Bayci AWL; Baker DA; Somerset AE; Turkoglu O; Hothem Z; Callahan RE; Mandal R; Han B; Bjorndahl T; Wishart D; Bahado-Singh R; Graham SF; Keidan R
Metabolomics; 2018 Aug; 14(8):105. PubMed ID: 30830422
[TBL] [Abstract][Full Text] [Related]
29. A serum lipidomic strategy revealed potential lipid biomarkers for early-stage cervical cancer.
Cheng F; Wen Z; Feng X; Wang X; Chen Y
Life Sci; 2020 Nov; 260():118489. PubMed ID: 32976882
[TBL] [Abstract][Full Text] [Related]
30. Identification of novel serum biomarker for the detection of acute myeloid leukemia based on liquid chromatography-mass spectrometry.
Wang D; Tan G; Wang H; Chen P; Hao J; Wang Y
J Pharm Biomed Anal; 2019 Mar; 166():357-363. PubMed ID: 30690249
[TBL] [Abstract][Full Text] [Related]
31. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
[TBL] [Abstract][Full Text] [Related]
32. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
33. Predicting ovarian cancer recurrence by plasma metabolic profiles before and after surgery.
Zhang F; Zhang Y; Ke C; Li A; Wang W; Yang K; Liu H; Xie H; Deng K; Zhao W; Yang C; Lou G; Hou Y; Li K
Metabolomics; 2018 Apr; 14(5):65. PubMed ID: 30830339
[TBL] [Abstract][Full Text] [Related]
34. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
35. Serum lipidomic profiling by UHPLC-MS/MS may be able to detect early-stage endometrial cancer.
Cheng F; Fan W; Gui L; Liu Y; Ling Y; Huang R; Wen Z; Chen Y
Anal Bioanal Chem; 2023 Apr; 415(10):1841-1854. PubMed ID: 36799979
[TBL] [Abstract][Full Text] [Related]
36. Altered levels of acylcarnitines, phosphatidylcholines, and sphingomyelins in peritoneal fluid from ovarian endometriosis patients.
Vouk K; Ribič-Pucelj M; Adamski J; Rižner TL
J Steroid Biochem Mol Biol; 2016 May; 159():60-9. PubMed ID: 26921767
[TBL] [Abstract][Full Text] [Related]
37.
Ye W; Lin Y; Bezabeh T; Ma C; Liang J; Zhao J; Ouyang T; Tang W; Wu R
NMR Biomed; 2021 Jun; 34(6):e4505. PubMed ID: 33783927
[TBL] [Abstract][Full Text] [Related]
38. Validation of metabolomic models for prediction of early-onset preeclampsia.
Bahado-Singh RO; Syngelaki A; Akolekar R; Mandal R; Bjondahl TC; Han B; Dong E; Bauer S; Alpay-Savasan Z; Graham S; Turkoglu O; Wishart DS; Nicolaides KH
Am J Obstet Gynecol; 2015 Oct; 213(4):530.e1-530.e10. PubMed ID: 26116099
[TBL] [Abstract][Full Text] [Related]
39. Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.
Röhnisch HE; Kyrø C; Olsen A; Thysell E; Hallmans G; Moazzami AA
BMC Med; 2020 Jul; 18(1):187. PubMed ID: 32698845
[TBL] [Abstract][Full Text] [Related]
40. Urinary Metabolomics to Identify a Unique Biomarker Panel for Detecting Colorectal Cancer: A Multicenter Study.
Deng L; Ismond K; Liu Z; Constable J; Wang H; Alatise OI; Weiser MR; Kingham TP; Chang D
Cancer Epidemiol Biomarkers Prev; 2019 Aug; 28(8):1283-1291. PubMed ID: 31151939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
